Regulatory

Regulatory
Japan’s MHLW approved Nubeqa and Docetaxel combination for mHSPC

Prostate Cancer -Feb 2023 Prostate Cancer – Feb 2023 27 Feb 2023:  Darolutamide (Oral) / Bayer / Orion Corporation: Received approval for mHSPC (ARASENS) in Japan Japan’s MHLW (The Ministry of Health, Labor and Welfare) has approved the Nubeqa + […]

by Sandhya Ramalingam

Continue Reading
Regulatory
Janssen received positive CHMP Opinion for AKEEGA

Prostate Cancer -Feb 2023 Prostate Cancer – Feb 2023 24 Feb 2023: Niraparib/ Abiraterone/(Oral) / Janssen: Positive CHMP Opinion for AKEEGA (Niraparib and Abiraterone acetate DAT) + Prednisone for BRCA1/2 mutant mCRPC  Summary: The CHMP has recommended approval for Akeega, a […]

by Sandhya Ramalingam

Continue Reading